ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FATE Fate Therapeutics Inc

4.00
-0.04 (-0.99%)
Last Updated: 05:10:39
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Fate Therapeutics Inc FATE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -0.99% 4.00 05:10:39
Open Price Low Price High Price Close Price Previous Close
3.97 3.91 4.13 4.04
more quote information »

Recent News

Date Time Source Heading
23/4/202406:30GLOBEFate Therapeutics Announces Presentation of FT819..
03/4/202423:00GLOBEFate Therapeutics to Present at 23rd Annual Needham Virtual..
03/4/202407:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
19/3/202423:44GLOBEFate Therapeutics Announces Pricing of $100 Million..
06/3/202408:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202408:01GLOBEFate Therapeutics Reports New Employee Inducement Award..
05/3/202405:29EDGAR2Form 144 - Report of proposed sale of securities
02/3/202400:00GLOBEFate Therapeutics to Present at Upcoming March Investor..
27/2/202408:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202408:03EDGAR2Form 8-K - Current report
27/2/202408:01GLOBEFate Therapeutics Reports Fourth Quarter and Full Year 2023..
16/2/202400:00GLOBEFate Therapeutics to Webcast Conference Call Reporting..
13/2/202410:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202408:01GLOBEFate Therapeutics Reports New Employee Inducement Awards..
31/1/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202405:44EDGAR2Form 144 - Report of proposed sale of securities
26/1/202408:19EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/1/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202408:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202408:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202408:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202408:39EDGAR2Form 144 - Report of proposed sale of securities
10/1/202408:36EDGAR2Form 144 - Report of proposed sale of securities
10/1/202408:36EDGAR2Form 144 - Report of proposed sale of securities
10/1/202408:35EDGAR2Form 144 - Report of proposed sale of securities
09/1/202400:00GLOBEFate Therapeutics Announces Initiation of Phase 1 Clinical..
04/1/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202404:17EDGAR2Form 144 - Report of proposed sale of securities
20/12/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202303:40EDGAR2Form 144 - Report of proposed sale of securities
14/12/202309:00GLOBEFate Therapeutics Reports New Employee Inducement Grants..
28/11/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/11/202303:57EDGAR2Form 144 - Report of proposed sale of securities
09/11/202309:10EDGAR2Form 8-K - Current report
09/11/202308:44EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202308:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:03EDGAR2Form 8-K - Current report
09/11/202308:01GLOBEFate Therapeutics Reports Third Quarter 2023 Financial..
25/10/202323:00GLOBEFate Therapeutics to Webcast Conference Call Reporting Third..
02/9/202307:29EDGAR2Form 8-K - Current report
31/8/202322:00GLOBEFate Therapeutics to Present at Upcoming September Investor..
22/8/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202305:58EDGAR2Form 144 - Report of proposed sale of securities
09/8/202306:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:07EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock